Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Barbiturate Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Ultra-Short Acting Barbiturate
1.3.3 Short-Acting Barbiturate
1.3.4 Long-Acting Barbiturate
1.3.5 Combination Drugs
1.4 Market Segment by Application
1.4.1 Global Barbiturate Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Barbiturate Drugs Market Size
2.1.1 Global Barbiturate Drugs Revenue 2014-2025
2.1.2 Global Barbiturate Drugs Sales 2014-2025
2.2 Barbiturate Drugs Growth Rate by Regions
2.2.1 Global Barbiturate Drugs Sales by Regions 2014-2019
2.2.2 Global Barbiturate Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Barbiturate Drugs Sales by Manufacturers
3.1.1 Barbiturate Drugs Sales by Manufacturers 2014-2019
3.1.2 Barbiturate Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Barbiturate Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Barbiturate Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Barbiturate Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Barbiturate Drugs Price by Manufacturers
3.4 Key Manufacturers Barbiturate Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Barbiturate Drugs Market
3.6 Key Manufacturers Barbiturate Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Ultra-Short Acting Barbiturate Sales and Revenue (2014-2019)
4.1.2 Short-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.3 Long-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.4 Combination Drugs Sales and Revenue (2014-2019)
4.2 Global Barbiturate Drugs Sales Market Share by Type
4.3 Global Barbiturate Drugs Revenue Market Share by Type
4.4 Barbiturate Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Barbiturate Drugs Sales by Application
6 United States
6.1 United States Barbiturate Drugs Breakdown Data by Company
6.2 United States Barbiturate Drugs Breakdown Data by Type
6.3 United States Barbiturate Drugs Breakdown Data by Application
7 European Union
7.1 European Union Barbiturate Drugs Breakdown Data by Company
7.2 European Union Barbiturate Drugs Breakdown Data by Type
7.3 European Union Barbiturate Drugs Breakdown Data by Application
8 China
8.1 China Barbiturate Drugs Breakdown Data by Company
8.2 China Barbiturate Drugs Breakdown Data by Type
8.3 China Barbiturate Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Barbiturate Drugs Breakdown Data by Company
9.2 Rest of World Barbiturate Drugs Breakdown Data by Type
9.3 Rest of World Barbiturate Drugs Breakdown Data by Application
9.4 Rest of World Barbiturate Drugs Breakdown Data by Countries
9.4.1 Rest of World Barbiturate Drugs Sales by Countries
9.4.2 Rest of World Barbiturate Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.1.4 Barbiturate Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.2.4 Barbiturate Drugs Product Introduction
10.2.5 Merck Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.3.4 Barbiturate Drugs Product Introduction
10.3.5 Eli Lilly Recent Development
10.4 Mylan
10.4.1 Mylan Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.4.4 Barbiturate Drugs Product Introduction
10.4.5 Mylan Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.5.4 Barbiturate Drugs Product Introduction
10.5.5 Sanofi Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.6.4 Barbiturate Drugs Product Introduction
10.6.5 Teva Pharmaceutical Recent Development
10.7 Sumitomo Dainippon Pharma
10.7.1 Sumitomo Dainippon Pharma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.7.4 Barbiturate Drugs Product Introduction
10.7.5 Sumitomo Dainippon Pharma Recent Development
10.8 Valeant Pharmaceuticals
10.8.1 Valeant Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.8.4 Barbiturate Drugs Product Introduction
10.8.5 Valeant Pharmaceuticals Recent Development
10.9 Oak Pharmaceuticals
10.9.1 Oak Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.9.4 Barbiturate Drugs Product Introduction
10.9.5 Oak Pharmaceuticals Recent Development
10.10 Meda pharmaceuticals
10.10.1 Meda pharmaceuticals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.10.4 Barbiturate Drugs Product Introduction
10.10.5 Meda pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Barbiturate Drugs Sales Channels
11.2.2 Barbiturate Drugs Distributors
11.3 Barbiturate Drugs Customers
12 Market Forecast
12.1 Global Barbiturate Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Barbiturate Drugs Sales Forecast by Type
12.3 Global Barbiturate Drugs Sales Forecast by Application
12.4 Barbiturate Drugs Forecast by Regions
12.4.1 Global Barbiturate Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Barbiturate Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Barbiturate Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Ultra-Short Acting Barbiturate
1.3.3 Short-Acting Barbiturate
1.3.4 Long-Acting Barbiturate
1.3.5 Combination Drugs
1.4 Market Segment by Application
1.4.1 Global Barbiturate Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Barbiturate Drugs Market Size
2.1.1 Global Barbiturate Drugs Revenue 2014-2025
2.1.2 Global Barbiturate Drugs Sales 2014-2025
2.2 Barbiturate Drugs Growth Rate by Regions
2.2.1 Global Barbiturate Drugs Sales by Regions 2014-2019
2.2.2 Global Barbiturate Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Barbiturate Drugs Sales by Manufacturers
3.1.1 Barbiturate Drugs Sales by Manufacturers 2014-2019
3.1.2 Barbiturate Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Barbiturate Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Barbiturate Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Barbiturate Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Barbiturate Drugs Price by Manufacturers
3.4 Key Manufacturers Barbiturate Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Barbiturate Drugs Market
3.6 Key Manufacturers Barbiturate Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Ultra-Short Acting Barbiturate Sales and Revenue (2014-2019)
4.1.2 Short-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.3 Long-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.4 Combination Drugs Sales and Revenue (2014-2019)
4.2 Global Barbiturate Drugs Sales Market Share by Type
4.3 Global Barbiturate Drugs Revenue Market Share by Type
4.4 Barbiturate Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Barbiturate Drugs Sales by Application
6 United States
6.1 United States Barbiturate Drugs Breakdown Data by Company
6.2 United States Barbiturate Drugs Breakdown Data by Type
6.3 United States Barbiturate Drugs Breakdown Data by Application
7 European Union
7.1 European Union Barbiturate Drugs Breakdown Data by Company
7.2 European Union Barbiturate Drugs Breakdown Data by Type
7.3 European Union Barbiturate Drugs Breakdown Data by Application
8 China
8.1 China Barbiturate Drugs Breakdown Data by Company
8.2 China Barbiturate Drugs Breakdown Data by Type
8.3 China Barbiturate Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Barbiturate Drugs Breakdown Data by Company
9.2 Rest of World Barbiturate Drugs Breakdown Data by Type
9.3 Rest of World Barbiturate Drugs Breakdown Data by Application
9.4 Rest of World Barbiturate Drugs Breakdown Data by Countries
9.4.1 Rest of World Barbiturate Drugs Sales by Countries
9.4.2 Rest of World Barbiturate Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.1.4 Barbiturate Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.2.4 Barbiturate Drugs Product Introduction
10.2.5 Merck Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.3.4 Barbiturate Drugs Product Introduction
10.3.5 Eli Lilly Recent Development
10.4 Mylan
10.4.1 Mylan Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.4.4 Barbiturate Drugs Product Introduction
10.4.5 Mylan Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.5.4 Barbiturate Drugs Product Introduction
10.5.5 Sanofi Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.6.4 Barbiturate Drugs Product Introduction
10.6.5 Teva Pharmaceutical Recent Development
10.7 Sumitomo Dainippon Pharma
10.7.1 Sumitomo Dainippon Pharma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.7.4 Barbiturate Drugs Product Introduction
10.7.5 Sumitomo Dainippon Pharma Recent Development
10.8 Valeant Pharmaceuticals
10.8.1 Valeant Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.8.4 Barbiturate Drugs Product Introduction
10.8.5 Valeant Pharmaceuticals Recent Development
10.9 Oak Pharmaceuticals
10.9.1 Oak Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.9.4 Barbiturate Drugs Product Introduction
10.9.5 Oak Pharmaceuticals Recent Development
10.10 Meda pharmaceuticals
10.10.1 Meda pharmaceuticals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.10.4 Barbiturate Drugs Product Introduction
10.10.5 Meda pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Barbiturate Drugs Sales Channels
11.2.2 Barbiturate Drugs Distributors
11.3 Barbiturate Drugs Customers
12 Market Forecast
12.1 Global Barbiturate Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Barbiturate Drugs Sales Forecast by Type
12.3 Global Barbiturate Drugs Sales Forecast by Application
12.4 Barbiturate Drugs Forecast by Regions
12.4.1 Global Barbiturate Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Barbiturate Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
